PresentationSteven SeedhouseMD & Biotechnology Analyst Okay. Well, thanks so much, everyone, and welcome to the next session. I'm Steve Seedhouse from the biotech team here at Cantor. And it's really a privilege for me to introduce our next presenting company, Pharvaris. I'm joined on stage by CCO, Wim Souverijns; and the CMO, Peng Lu. I'm really looking forward to the conversation. Obviously, Pharvaris is developing deucrictibant. It's a very exciting molecule for HAE. And in lieu of me saying more, I woul ...